Identification and characterization of novel long non-coding RNAs in AKI-to-CKD transition using CRISPR/Cas9-based epigenome editing: Revealing the potential of the long non-coding RNAs as a biomarker and therapeutic strategy
Identification and characterization of novel long non-coding RNAs in AKI-to-CKD transition using CRISPR/Cas9-based epigenome editing: Revealing the potential of the long non-coding RNAs as a biomarker and therapeutic strategy